|Mr. Andrew H. Galligan||Chief Financial Officer||693.26k||1.28M||1956|
|Mr. Patrick Schmitz||VP of Operations||466.66k||N/A||1960|
|Mr. Kashif Rashid||Gen. Counsel, Corp. Sec. & Chief Compliance Officer||502.18k||N/A||1974|
|Mr. Doug Alleavitch||VP of Quality||466.66k||14.16k||1961|
|Mr. D. Keith Grossman||Chairman, CEO & Pres||N/A||N/A||1960|
Nevro Corp., a medical device company, provides products for the patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. Its solution for chronic pain also includes HF10 Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was founded in 2006 and is headquartered in Redwood City, California.
Nevro Corp.’s ISS Governance QualityScore as of October 4, 2019 is 7. The pillar scores are Audit: 2; Board: 7; Shareholder Rights: 4; Compensation: 9.